http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004075695-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
filingDate 2003-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_604676f613c6fea5543b5f462ad6d32c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f48ca1854b7b80611727fcf1a44e909d
publicationDate 2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004075695-A
titleOfInvention Treatment and control of eye development
abstract 【Task】 To provide an agent for inhibiting abnormal postnatal axial growth of the eye of a mature animal during the postnatal maturation period of the animal. [Solution] An agent for inhibiting abnormal postnatal axial growth of the eye of a mature animal during the postnatal maturation period, comprising a therapeutically effective amount of relatively brain, neural tissue and / or ganglion cells M 1 is cholinergic receptors in that block is selective, in that block M 3 cholinergic receptors in cells of the smooth muscle in the front of the eye has a weaker selectivity in, M 3 smooth having an affinity for at least 5 times greater M 1 receptor than for muscle receptor, and comprises an effective muscarinic pharmacological antagonist in inhibiting abnormal postnatal axial growth of the eye (but pirenzepine, telenzepine and (Excluding muscarinic pharmacological antagonists, which are tricyclic compounds).
priorityDate 1989-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447835882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139835349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415827775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4694097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410023599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420261318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3082762

Total number of triples: 65.